Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of defibrillation and CPR-gear specialist Zoll Medical
So what: This stock plunged face-first on Monday because of a dire new risk outlined in the freshly filed 10-Q: LifeVest products might not get the wide market access they were expected to gain. Today, Zoll executives took part in a conference call arranged by Jefferies to calm frazzled investor nerves -- and it looks like that worked to some degree.
Now what: I don't know what was said during that fateful call, but the bulk of today's climb started along with the phone action and ended when they hung up. Whatever the message -- nitpicked by a supposedly independent doctor selected by Jefferies -- ZOLL is still set to close the week some 22% lower. And before writing that off as just getting caught in the general market panic, consider that sector rivals Medtronic
Interested in more info on ZOLL Medical? Add it to your watchlist.